tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vanguard Total Stock Market ETF (VTI) Daily Update—12/22/25

Story Highlights

Let’s take a quick look at how the Vanguard Total Stock Market ETF has been performing.

Vanguard Total Stock Market ETF (VTI) Daily Update—12/22/25

The Vanguard Total Stock Market ETF (VTI), which provides broad exposure to the entire U.S. stock market, is up 0.10% in premarket trading on Monday. Overall, U.S. stock futures climbed Monday, kicking off a short holiday week, as traders eye whether tech can rebound before year-end.

Claim 50% Off TipRanks Premium and Invest with Confidence

Overall, the VTI ETF is down by 0.26% over the past five days but up 17.10% year-to-date.

More Details on VTI ETF   

VTI’s three-month average trading volume is 4.12 million shares. However, its 5-day net flows were negative $2 billion, implying significant investor outflows despite steady trading activity. This could signal short-term selling pressure or profit-taking in the ETF.

VTI’s Top Holdings

Currently, VTI holds 3,488 stocks with total assets worth $566.11 billion. Its top positions are:

VTI’s Price Forecasts and Holdings

According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of analyst ratings on its holdings, VTI is a Moderate Buy. The Street’s average price target of $396.02 implies an upside of 17.8%. 

Currently, VTI’s five holdings with the highest upside potential are:

  1. Direct Digital Holdings (DRCT)
  2. Jupiter Neurosciences (JUNS)
  3. FibroBiologics, Inc. (FBLG)
  4. Adicet Bio Inc (ACET)
  5. NRX Pharmaceuticals (NRXP)

Meanwhile, its holdings with the greatest downside potential are:

  1. Outlook Therapeutics (OTLK)
  2. Athira Pharma (ATHA)
  3. AXT Inc. (AXTI)
  4. Puma Biotechnology (PBYI) 

Notably, VTI ETF’s Smart Score is seven, implying that this ETF is likely to perform in line with the broader market.

Power up your ETF investing with TipRanks. Discover the Best AI ETFs, carefully curated based on TipRanks’ analysis.  

Disclaimer & DisclosureReport an Issue

1